Nephrotic syndrome following allogeneic stem cell transplantation associated with increased production of TNF-alpha and interferon-gamma by donor T cells

被引:44
作者
Seconi, J
Watt, V
Ritchie, DS
机构
[1] Wellington Sch Med, Malaghan Inst Med Res, Wellington, New Zealand
[2] Capital & Coast Hlth Ltd, Wellington Canc Ctr, Wellington, New Zealand
关键词
graft-versus-host disease; nephrotic syndrome; TNF-alpha;
D O I
10.1038/sj.bmt.1704151
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Tumor necrosis factor-alpha (TNF-alpha) has been implicated in the immunological complications of stem cell transplantation (SCT) including graft-versus-host disease (GVHD). In this report of a patient undergoing allogeneic SCT for AML, serial cytokine measurements by real-time PCR revealed increased production of interferon-gamma (IFN-gamma) and TNF-alpha, but not interleukin (IL)-4 in purified T cells following withdrawal of immunosuppression. Cytokine changes were contemporaneous with the onset of nephrotic syndrome (NS), a rare manifestation of GVHD. These findings indicate that serial cytokine monitoring may allow for the prediction of GVHD during immunosuppression withdrawal and lend further insight into the pathogenesis of NS.
引用
收藏
页码:447 / 450
页数:4
相关论文
共 9 条
[1]  
BURNETT A, MED RES COUNCIL ACUT
[2]   Tumor necrosis factor-α production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graft-versus-host disease [J].
Cooke, KR ;
Hill, GR ;
Crawford, JM ;
Bungard, D ;
Brinson, YS ;
Delmonte, J ;
Ferrara, JLM .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (10) :1882-1891
[3]  
Kim YS, 2001, CLIN NEPHROL, V56, P199
[4]   T-lymphocyte populations and cytokines in childhood nephrotic syndrome [J].
Lama, G ;
Luongo, I ;
Tirino, G ;
Borriello, A ;
Carangio, C ;
Salsano, ME .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (05) :958-965
[5]   Nephrotic syndrome as a clinical manifestation of graft-versus-host disease (GVHD) in a marrow transplant recipient after cyclosporine withdrawal [J].
Oliveira, JSR ;
Bahia, D ;
Franco, M ;
Balda, C ;
Stella, S ;
Kerbauy, J .
BONE MARROW TRANSPLANTATION, 1999, 23 (01) :99-101
[6]  
Ruutu T, 2000, BLOOD, V96, P2391
[7]  
SATO N, 1995, BONE MARROW TRANSPL, V16, P303
[8]   Donor T cell-derived TNF is required for graft-versus-host disease and graft-versus-tumor activity after bone marrow transplantation [J].
Schmaltz, C ;
Alpdogan, O ;
Muriglan, SJ ;
Kappel, BJ ;
Rotolo, JA ;
Ricchetti, ET ;
Greenberg, AS ;
Willis, LM ;
Murphy, GF ;
Crawford, JM ;
van den Brink, MRM .
BLOOD, 2003, 101 (06) :2440-2445
[9]   Acute graft-versus-host disease does not require alloantigen expression on host epithelium [J].
Teshima, T ;
Ordemann, R ;
Reddy, P ;
Gagin, S ;
Liu, C ;
Cooke, KR ;
Ferrara, JLM .
NATURE MEDICINE, 2002, 8 (06) :575-581